Singapore, April 14 -- Japan-based Nippon Shinyaku has entered into a collaboration agreement with xFOREST Therapeutics with the aim to create novel pharmaceuticals targeting RNA structures. 

Published by HT Digital Content Services with permission from BioSpectrum Asia....